Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents.

Journal of hepatology - 1 Jun 2010

Sokal Etienne M, Bourgois Annick, Stéphenne Xavier, Silveira Themis, Porta Gilda, Gardovska Dace, Fischler Björn, Kelly Deirdre

Abstract excerpt

BACKGROUND & AIMS: This multi-center study aimed to prospectively evaluate the safety and efficacy of a genotype-based Pegylated Interferon alfa-2a/Ribavirin therapy in treatment-naïve hepatitis C virus (HCV), positive HCV serology, and quantifiable HCV RNA, infected children. METHODS: Eighteen children with genotypes 2 and 3 patients (group A) were assigned to medication for 24weeks, and 47 children with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Predictive Value of Tests

Share to Ribavirin

Source

Identifiers

PMID: 20400194
DOI: 10.1016/j.jhep.2010.01.028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents.PMID 20400194Read ↗

Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C.Semantic proximity Read ↗

Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.Semantic proximity Read ↗

Safety and Efficacy of Combined Treatment with Pegylated Interferon Alpha-2b and Ribavirin for HCV Genotype 4 in Children.Semantic proximity Read ↗

Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children.Semantic proximity Read ↗

High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin.Semantic proximity Read ↗

Systematic review with meta-analysis: comparison between therapeutic regimens for paediatric chronic hepatitis C.Semantic proximity Read ↗

Treatment of hepatitis C in children: a systematic review.Semantic proximity Read ↗

Treatment for chronic hepatitis C in children: a review.Semantic proximity Read ↗

Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents.Semantic proximity Read ↗

Efficacy of pegylated interferon α-2b and ribavirin in chronic hepatitis C virus (genotypes 1 and 4) infection.Semantic proximity Read ↗

Effectiveness and Safety of Sofosbuvir in Treatment-NäiveChildren with Hepatitis C Infection.Semantic proximity Read ↗

Hepatitis C Virus in Children: Deferring Treatment in Expectation of Direct-Acting Antiviral Agents.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.